Rapid Symptom Improvement in Major Depressive Disorder Using Accelerated Repetitive Transcranial Magnetic Stimulation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Repetitive transcranial magnetic stimulation (rTMS) has contributed to increase in the remission rate for patients with major depressive disorder (MDD). However, current rTMS treatment is practically inconvenient because it requires daily treatment sessions for several weeks. Accelerated rTMS treatment is as efficient and safe for MDD patients as conventional rTMS. Methods: Fifty-one patients with MDD participated in this study; they were randomized into accelerated rTMS (n = 21), conventional rTMS (n = 22), and sham-treatment (n = 8) groups. The accelerated and conventional rTMS groups received 15 sessions for 3 days and 3 weeks, respectively. The sham-treatment group received 15 sham rTMS sessions for 3 days. Primary outcome was assessed using self-report and clinician-rated Korean Quick Inventory of Depressive Symptomatology (KQIDS-SR and KQIDS-C, respectively). Adverse effects were monitored using the Frequency, Intensity, and Burden of Side Effects Rating scale. Changes in depressive symptoms were compared among the three groups using mixed model analyses. Results: For the KQIDS-SR score, there was a significant main effect of “time” (F3,47 = 11.05, p ＜ 0.001), but no effect of “group” (F2,47 = 2.04, p = 0.142), and a trend-level interaction effect of “group × time” (F6,47 = 2.26, p = 0.053). Improvement in depressive symptoms, based on the KQIDS-SR score 3 weeks after treatment, was more prominent in the accelerated rTMS group than in the sham-treatment group (p = 0.011). Tolerability was comparable among the three groups. Conclusion: The accelerated rTMS treatment group showed rapid improvement of depressive symptoms compared with the sham-treatment and conventional rTMS treatment groups. Therefore, accelerated rTMS treatment could be a viable option for MDD, with improved accessibility.
Abstract
Objective: Repetitive transcranial magnetic stimulation (rTMS) has contributed to increase in the remission rate for patients with major depressive disorder (MDD). However, current rTMS treatment is practically inconvenient because it requires daily treatment sessions for several weeks. Accelerated rTMS treatment is as efficient and safe for MDD patients as conventional rTMS. Methods: Fifty-one patients with MDD participated in this study; they were randomized into accelerated rTMS (n = 21), conventional rTMS (n = 22), and sham-treatment (n = 8) groups. The accelerated and conventional rTMS groups received 15 sessions for 3 days and 3 weeks, respectively. The sham-treatment group received 15 sham rTMS sessions for 3 days. Primary outcome was assessed using self-report and clinician-rated Korean Quick Inventory of Depressive Symptomatology (KQIDS-SR and KQIDS-C, respectively). Adverse effects were monitored using the Frequency, Intensity, and Burden of Side Effects Rating scale. Changes in depressive symptoms were compared among the three groups using mixed model analyses. Results: For the KQIDS-SR score, there was a significant main effect of “time” (F3,47 = 11.05, p ＜ 0.001), but no effect of “group” (F2,47 = 2.04, p = 0.142), and a trend-level interaction effect of “group × time” (F6,47 = 2.26, p = 0.053). Improvement in depressive symptoms, based on the KQIDS-SR score 3 weeks after treatment, was more prominent in the accelerated rTMS group than in the sham-treatment group (p = 0.011). Tolerability was comparable among the three groups. Conclusion: The accelerated rTMS treatment group showed rapid improvement of depressive symptoms compared with the sham-treatment and conventional rTMS treatment groups. Therefore, accelerated rTMS treatment could be a viable option for MDD, with improved accessibility.
참고문헌 (25)
- Preventing suicide: a global imperative, "World Health Organization", World Health Organization, ~ (2014)
- Mental health action plan 2013-2020, "World Health Organization", World Health Organization, 48~ (2013)
- Kessler RC, "The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)", JAMA, 289, pp.3095~3105 (2003)
- Srisurapanont M, "MD RAN. Clinical features of depression in Asia: results of a large prospective, cross-sectional study", Asia Pac Psychiatry, 5, pp.259~267 (2013)
- Whiteford HA, "The global burden of mental, neurological and substance use disorders : an analysis from the Global Burden of Disease Study 2010", PLoS One, 10, pp.e0116820~ (2015)
- Lin CH, "Depression and pain impair daily functioning and quality of life in patients with major depressive disorder", J Affect Disord, 166, pp.173~178 (2014)
- Sinyor M, "The sequenced treatment alternatives to relieve depression(STAR*D)trial : a review", Can J Psychiatry, 55, pp.126~135 (2010)
- Sackeim HA, "The cognitive effects of electroconvulsive therapy in community settings", Neuropsychopharmacology, 32, pp.244~254 (2007)
- Martin DM, "Does therapeutic repetitive transcranial magnetic stimulation cause cognitive enhancing effects in patients with neuropsychiatric conditions? A systematic review and meta-analysis of randomised controlled trials", Neuropsychol Rev, 26, pp.295~309 (2016)
- Brunoni AR, "Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes : a systematic review with network meta-analysis", JAMA Psychiatry, 74, pp.143~152 (2017)
- Gaynes BN, "Repetitive transcranial magnetic stimulation for treatment-resistant depression : a systematic review and meta-analysis", J Clin Psychiatry, 75, pp.477~489 (2014)
- Liu B, "Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study", BMC Psychiatry, 14, pp.342~ (2014)
- Milev RV, "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: section 4. neurostimulation treatments", Can J Psychiatry, 61, pp.561~575 (2016)
- Schulze L, "Number of pulses or number of sessions? An open-label study of trajectories of improvement for once-vs. twice-daily dorsomedial prefrontal rTMS in major depression", Brain Stimul, 11, pp.327~336 (2018)
- Modirrousta M, "Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder : a retrospective study", Neuropsychiatr Dis Treat, 14, pp.309~316 (2018)
- McGirr A, "Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation(rTMS)for treatment-resistant major depressive disorder : an open label trial", J Affect Disord, 173, pp.216~220 (2015)
- George MS, "A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation(rTMS)for suicidal inpatients", Brain Stimul, 7, pp.421~431 (2014)
- Fitzgerald PB, "Accelerated repetitive transcranial magnetic stimulation in the treatment of depression", Neuropsychopharmacology, 43, pp.1565~1572 (2018)
- Loo CK, "A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression", Psychol Med, 37, pp.341~349 (2007)
- Baeken C, "Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients", J Affect Disord, 151, pp.625~631 (2013)
- Mishory A, "The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision", J ECT, 20, pp.160~165 (2004)
- Chervyakov AV, "Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation", Front Hum Neurosci, 9, pp.303~ (2015)
- Cirillo G, "Neurobiological after-effects of non-invasive brain stimulation", Brain Stimul, 10, pp.1~18 (2017)
- Baeken C, "The impact of accelerated high frequency rTMS on brain neurochemicals in treatment-resistant depression : insights from 1H MR spectroscopy", Clin Neurophysiol, 128, pp.1664~1672 (2017)
- Uher R, "Self-report and clinician-rated measures of depression severity: can one replace the other?", Depress Anxiety, 29, pp.1043~1049 (2012)